Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patientsGaojie Liu, Bing Zeng|Journal of Translational Medicine|2015Cited by 99
miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinomaJianping Liu, Gaojie Liu|Oncology Reports|2017Cited by 15